Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial |
| |
摘 要: |
|
收稿时间: | 2009-01-21 |
本文献已被 SpringerLink 等数据库收录! |
|